Eyenovia Inc (NASDAQ:EYEN) does about 330.19K shares in volume on a normal day but saw 142189 shares change hands in the recent trading day. The company now has a market cap of 308.80M USD. Its current market price is $2.77, marking a decrease of -0.86% compared to the previous close of $2.79. The 52 week high reached by this stock is $2.57 whilst the lowest price level in 52 weeks is $0.03.
Eyenovia Inc (EYEN) has a 20-day trading average at $0.0780 and the current price is 7.70% off the 52-week high compared with 8604.40% distance from its 52-week low. The 50-day simple moving average of the closing price is $0.0891 and its 200-day simple moving average is $0.5490. If we look at the stock’s price movements over the week, volatility stands at 17.79%, which increases to 22.01% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 29.97 to suggest the stock is oversold.
The consensus objective for the share price is $2.00, suggesting that the stock has a potential downside of -38.5% over the period.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on November 18, 2024 when H.C. Wainwright downgraded the stock to “Neutral” and issued a price target of between $12 and $2.
The current price level is 3447.81%, 3005.09%, and 404.19% away from its SMA20, SMA50, and SMA200 respectively, with the EYEN price moving below the 50-day SMA on current market day. Eyenovia Inc (EYEN) stock is down -39.40% over the week and -69.46% over the past month. Its price is -76.30% year-to-date and -98.20% over the past year.
The company’s next earnings report forecasts estimating quarterly EPS at -8.0 and -49.6 for whole year. In addition, estimates put the company’s current quarterly revenue at an average of $1.6M.
To reach the target analysts have set, the stock logically needs to shrink -38.5 percent from here.
Outstanding shares total 111.42M with insiders holding 10.00% of the shares and institutional holders owning 13.73% of the company’s common stock. The company has a return on investment of -564.90% and return on equity of -388.03%. The beta has a value of 1.25. Price to book ratio is 64.28 and price to sales ratio is 10293.33.
